How countries are failing to integrate people with mental illness into society
Related content

Mental health and integration
Mental illness is the second largest contributor to years lost due to disability (YLDs) in the Asia-Pacific region. Nowhere, though, do more than half of those affected receive any medical treatment. This is not some temporary crisis. It is business as usual.
Across the region, policy makers and health systems are taking note. In 2010, Japan declared mental illness to be one of just five priority diseases; China passed its first ever mental health law in 2012; Indonesia significantly modernised its legislation in 2014 and India adopted its first mental health policy the same year. Meanwhile, at the international level, APEC and ASEAN have also begun to engage with the issue.

Mental health is everyone’s business
The huge cost of mental health problems to employers has become more widely recognised. It is important that employees have ownership and take leadership of the mental health agenda, including openly sharing their experiences of mental health problems, argues Sue Baker, Director of Time to Change, England’s largest ever programme to end mental health stigma and discrimination.
Just as mental health issues, including depression, are a global issue so, sadly, are the stigma, shame and discrimination experienced by those of us with mental health problems. This is most present within families, friends, and at work.
In the UK, despite the fact that one in six workers is experiencing depression, anxiety or stress, many do not feel able to discuss this at work or seek support. The earlier people access help, the better. If they have to take time off, a supported return to work as people recover can lead to more positive outcomes for both the employee and the employer. A preventative focus on the resilience and wellbeing of all staff and a culture of openness are also needed.
Mental health issues themselves do not discriminate—they can happen to anyone. However, the factors and work practices that contribute to poor mental health, and undermine mental wellbeing at work, are well recognised, including poor management, excessive workloads, threat of redundancy and lack of autonomy. Therefore, we also know what could help promote and protect the mental health and wellbeing of the whole workforce.
Whilst there have been significant improvements in public attitudes in recent years, 49% of adults say they would feel uncomfortable talking to their employer about their own mental health.
The huge cost of mental health problems to employers has become more widely recognised with presenteeism (attending work while sick), absenteeism and staff turnover due to mental illness costing British business nearly £26bn a year and an average of £1,035 per employee; the total costs of mental ill-health in the UK equate to £70bn or 4.5% of GDP according the OECD. If employees are not getting the right support and not feeling comfortable enough to open up, these costs will remain very high. However, if workplaces can implement the right practices and create the right culture, it will not only be better for staff but will also make economic sense.
A third of UK employers that my organisation works with have made changes to policy, a quarter have delivered training for line managers (who have a key role to play), and two thirds have delivered mental health awareness to all staff, including resilience building, mindfulness and Mental Health First Aid.
The importance of sharing experiences
As well as ownership and leadership at board and executive level, we have also seen the vital importance of staff having ownership and taking leadership of this agenda, including openly sharing their experiences of mental health problems; this can be transformational in relation to achieving culture change. Hearing from a colleague with first-hand experience can unlock a more open dialogue and culture, as well as changing attitudes and overturning stereotypes. In the UK, we are seeing some top business leaders, executives, managers and staff at all levels share their experiences of mental health problems; and we are witnessing the powerful change this can bring about.
We would like to see this in all workplaces; silence has existed for too long. The economic, social and human costs of stigma are too high a price to pay for inaction.
Other powerful forces are also shaping our workplace culture. The way we work is changing and in-demand skills such as teamwork, collaboration, joint problem solving, flexible working and staff development all require employees who are mentally healthy, resilient, motivated and focused. Good mental health should become core business for all employers.
Sue Baker will be one of the speakers at an upcoming Economist conference, The Global Crisis of Depression. Some of the issues discussed in this blog will be explored further at a panel discussion on "The challenge of depression in the workplace".
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of The Economist Intelligence Unit Limited (EIU) or any other member of The Economist Group. The Economist Group (including the EIU) cannot accept any responsibility or liability for reliance by any person on this article or any of the information, opinions or conclusions set out in the article.

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.
Mental health and integration - Korean
정신 질환은 아시아 태평양 지역에서 장애로인해 손실된 연수(YLDs)에 기여하는 두 번째주요 원인이다. 그러나 이 지역에서 정신 질환환자들의 절반 이상이 어떠한 의료적 치료를받고 있는 국가는 없다. 이는 일시적인 위기가아닌 일상적인 문제이다.
이 지역의 정책 결정자들과 의료 시스템이 이문제에 주목하고 있다. 2010년 일본이 정신질환을 5대 질병 중 하나로 선언했고 중국이2012년 중국에서 처음으로 정신보건법을통과시켰다. 인도네시아는 2014년 법체계를상당한 수준으로 정비했고 인도에서는 2014년처음으로 정신보건 정책을 채택했다. 국제적인차원에서 APEC과 ASEAN이 이 문제에 관심을가지기 시작했다.
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Mental health and integration - Chinese
在亚太地区,精神疾病是伤残所致生命年损失(years lost due to disability/YLD) 的第二大因素。尽管如此,在整个亚太地区,仍有超过半数的精神疾病患者无法获得治疗。这并不是一个新的危机,而是一个长期存在的问题。
在整个亚太地区,政策制定者和医疗体系的都在积极应对此问题。2010 年,日本宣布精神疾病成为日本五大重点疾病之一;2012 年,中国通过了第一部精神卫生法——《中华人民共和国精神卫生法》;2014 年,印度尼西亚大幅修改了立法;同年,印度首度制定了首部精神卫生相关政策。与此同时,在国际层面,亚太经合组织 (Asia-Pacific Economic Cooperation/APEC) 和东盟 (Associationof Southeast Asian Nations/ASEAN) 也开始关注精神卫生相关议题。
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Mental health and integration - Japanese
アジア太平洋地域では、障害を有することによって失われた年数(以下、YLD)の原因疾患の第2 位は精神疾患です。しかし、こうした患者の半数以上が何らかの医学的な治療を受けられている国・地域はありません。これは一過性の危機ではありません。これが常態化しているのです。
世界では政策決定者や医療界がこの問題に気付き始めています。日本では2012 年に医療法に定める5 疾病の一つに加えられました。中国では2012 年に、初の精神衛生法が制定されました。2014 年にはインドネシアの国内法が大幅に近代化され、インドでも初の精神衛生政策が採用されました。また国際的なレベルでは、APEC およびASEAN もこれらの問題への取り組みを開始しました。
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Mental health and integration
Mental illness is the second largest contributor to years lost due to disability (YLDs) in the Asia-Pacific region. Nowhere, though, do more than half of those affected receive any medical treatment. This is not some temporary crisis. It is business as usual.
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Mental health and integration
Mental illness is the second largest contributor to years lost due to disability (YLDs) in Asia-Pacific. Nowhere, though, do more than half of those affected receive any medical treatment. Across the region, policy makers and health systems are taking note.
More from this series

white paper
Mental health and integration
Mental illness is the second largest contributor to years lost due to disability (YLDs) in the Asia-Pacific

white paper
Mental health and integration - Chinese
在亚太地区,精神疾病是伤残所致生命年损失(years lost due to disability/YLD

white paper
Mental health and integration - Japanese
アジア太平洋地域では、障害を有することによって失われた年数(以下、YLD

white paper
Mental health and integration - Korean
정신 질환은 아시아 태평양 지역에서 장애로인해 손실된 연수(YLDs
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Happy homes
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.
Mental health and integration
Mental illness exacts a substantial human and economic toll on Europe. World Health Organisation (WHO) estimates for 2012 show that in the 30 countries covered by this study, 12% of all disability-adjusted life years (DALYs)—a measure of the overall disease burden—were the direct result of mental illness. These conditions almost certainly also contributed to the large number of DALYs attributed to other chronic diseases. On the economic front, the best estimates are that mental illness cuts GDP in Europe annually by 3-4%.
Related content

Value-based healthcare in Sweden: Reaching the next level
The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.
These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.
This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Breast cancer patients and survivors in the Asia-Pacific workforce
With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?
This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.
The Cost of Silence
Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.
As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.
To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.
Download the report to learn more.